The employed treatment planning solutions were Brainlab Elements - Multiple Brain Mets SRS - version 3 (MBM) and Varian - HyperArc - Eclipse 16.1 (HA).
The main difference between both systems is the treatment technique. HA utilizes RapidArc-VMAT and MBM depends on multi-aperture dynamic conformal arcs. Similarities include jaw tracking and using a single isocenter at the centroid of all targets.
Furthermore, beam data is the same and origins from a Varian TrueBeam STx LINAC.
Both systems can operate highly automated but were influenced by the same planner to ensure that prescription coverage was tolerable (98.5% ± 1%) and no SRS dose constraints (QUANTEC) were violated.
Ten cases with a total of 70 metastases (mean volume 1.1cc ± 0.9cc) were compared. The prescription of 20Gy was the same for all metastases.